Trials / Unknown
UnknownNCT04202653
Combination of ETV, TQ-A3334 and TQ-B2450 for CHB (Neptune Study)
New Combination of ETV, TQ-A3334 and TQ-B2450 for the Treatment of Chronic Hepatitis B Virus Infection
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Tongji Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
This study is a single-center, randomized, prospective, open-label Phase 2 Clinical trial to evaluate efficacy and safety of ETV and TQ-A3334 combinated with/without inhibitor of TQ-B2450 versus ETV alone in chronic hepatitis B patients. Patients were randomized to one of 3 different antiviral treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ETV | entecavir 0.5 mg qd |
| DRUG | TQ-A3334 | TQ-A3334 po qw |
| DRUG | TQ-B2450 | TQ-B2450 q3w iv |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2020-12-31
- Completion
- 2021-06-30
- First posted
- 2019-12-17
- Last updated
- 2019-12-19
Source: ClinicalTrials.gov record NCT04202653. Inclusion in this directory is not an endorsement.